Evaluation of Oral Collagen Peptides on Skin Barrier Function in Women
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age45-70
SponsorCentre de Pharmacologie Clinique Applique a la Dermatologie
About this trial
This clinical study aims to determine whether taking two different doses of collagen-derived peptides for three months improves facial skin barrier integrity in women with dry, sensitive skin, compared with a placebo.
Eligibility criteria
Qualifiers
Participant having signed an Informed Consent Form (ICF);
Healthy female Participant aged 45 to 70 years inclusive not followed by a healthcare practitioner for any skin disease;
Participant with phototype II to IV according to the Fitzpatrick classification;
Participant with dry skin measured on the cheeks (Tewameter, TEWL >15g/m²/h (skin barrier integrity) on back of the cheekbone)
Disqualifiers
Participant with a BMI ≤17 or ≥30 kg/cm²;
Participant with any uncontrolled diseases such as diabetes, hypertension, hyperthyroidism or hypothyroidism;
Presenting or having a history of eating disorder (e.g. anorexia, food allergy) or gastrointestinal malabsorption such as celiac disease, Crohn's disease, lactose intolerance;
Participant with an history of sleeve or bypass;
Trial design
Treatments tested in this trial
- Investigational Product 1
- Investigational Product 2
- Placebo
Treatment groups
75 Participants
are divided into 3 treatment groupsSponsors and collaborators
Centre de Pharmacologie Clinique Applique a la Dermatologie
Lead sponsor
Rousselot BVBA
Collaborator
Source ClinicalTrials.gov